Patents by Inventor Dean Michael Karantonis

Dean Michael Karantonis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210315502
    Abstract: An implantable device for estimating neural recruitment arising from a stimulus, has a plurality of electrodes. A stimulus source provides stimuli to be delivered from the electrodes to neural tissue. Measurement circuitry obtains a measurement of a neural signal sensed at the electrodes. A control unit is configured to control application of a selected stimulus to neural tissue using the stimulus electrodes; and after the selected neural stimulus, apply a probe stimulus having a short pulse width. A remnant neural response evoked by the probe stimulus is measured; and the control unit estimates from the remnant neural response a neural recruitment caused by the selected neural stimulus.
    Type: Application
    Filed: June 22, 2021
    Publication date: October 14, 2021
    Applicant: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, James Hamilton Wah, Dean Michael Karantonis
  • Patent number: 11045129
    Abstract: An implantable device for estimating neural recruitment arising from a stimulus, has a plurality of electrodes. A stimulus source provides stimuli to be delivered from the electrodes to neural tissue. Measurement circuitry obtains a measurement of a neural signal sensed at the electrodes. A control unit is configured to control application of a selected stimulus to neural tissue using the stimulus electrodes; and after the selected neural stimulus, apply a probe stimulus having a short pulse width. A remnant neural response evoked by the probe stimulus is measured; and the control unit estimates from the remnant neural response a neural recruitment caused by the selected neural stimulus.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: June 29, 2021
    Assignee: Saluda Medical Pty Ltd.
    Inventors: John Louis Parker, James Hamilton Wah, Dean Michael Karantonis
  • Publication number: 20210001133
    Abstract: A system for managing clinical data of an implanted neuromodulation device. An implanted neuromodulation device delivers electrical neurostimulation therapy, and captures recordings of neural responses to the electrical neurostimulation therapy. The device communicates clinical data including recordings of the neural responses to a non-implanted receiver. A supervisory device receives clinical data from the implanted neuromodulation device via the receiver, and presents the clinical data for review by a reviewer.
    Type: Application
    Filed: March 23, 2018
    Publication date: January 7, 2021
    Applicant: Saluda Medical Pty Ltd
    Inventors: Matthew Marlon Williams, Dean Michael Karantonis, Ivan Guelton, Robert Bruce Gorman
  • Publication number: 20200129108
    Abstract: A method for determining a desired location at which to apply a neural therapy. An array of electrodes is positioned proximal to neural tissue. A stimulus is applied from the array which evokes a neural compound action potential response in the neural tissue proximal to the array. A plurality of electrodes of the array simultaneously obtain respective measurements of the neural compound action potential response. From the measurements of the neural compound action potential response a desired location for a neural therapy is determined.
    Type: Application
    Filed: December 24, 2019
    Publication date: April 30, 2020
    Applicant: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Dean Michael Karantonis
  • Patent number: 10568559
    Abstract: A method for determining a desired location at which to apply a neural therapy. An array of electrodes is positioned proximal to neural tissue. A stimulus is applied from the array which evokes a neural compound action potential response in the neural tissue proximal to the array. A plurality of electrodes of the array simultaneously obtain respective measurements of the neural compound action potential response. From the measurements of the neural compound action potential response a desired location for a neural therapy is determined.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: February 25, 2020
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Dean Michael Karantonis
  • Publication number: 20190307341
    Abstract: A method for measuring a neural response to a stimulus. Measurement circuitry is settled prior to a stimulus, by connecting a sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state. Charge is recovered on stimulus electrodes by short circuiting the stimulus electrodes to each other. An electrical stimulus is then applied from the stimulus electrodes to neural tissue, while keeping the sense electrode disconnected from the measurement circuitry. After the stimulus, a delay is imposed during which the stimulus electrodes are open circuited and the sense electrode is disconnected from the measurement circuitry and from the stimulus electrodes. After the delay, a neural response signal present at the sense electrode is measured by connecting the sense electrode to the measurement circuitry.
    Type: Application
    Filed: April 22, 2019
    Publication date: October 10, 2019
    Applicant: Saluda Medical Pty Ltd.
    Inventors: John Louis Parker, Peter Scott Vallack Single, Dean Michael Karantonis
  • Patent number: 10278600
    Abstract: A method for measuring a neural response to a stimulus. Measurement circuitry is settled prior to a stimulus, by connecting a sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state. Charge is recovered on stimulus electrodes by short circuiting the stimulus electrodes to each other. An electrical stimulus is then applied from the stimulus electrodes to neural tissue, while keeping the sense electrode disconnected from the measurement circuitry. After the stimulus, a delay is imposed during which the stimulus electrodes are open circuited and the sense electrode is disconnected from the measurement circuitry and from the stimulus electrodes. After the delay, a neural response signal present at the sense electrode is measured by connecting the sense electrode to the measurement circuitry.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: May 7, 2019
    Assignee: Saluda Medical Pty Ltd.
    Inventors: John Louis Parker, Peter Scott Vallack Single, Dean Michael Karantonis
  • Publication number: 20180256052
    Abstract: An implantable device for estimating neural recruitment arising from a stimulus, has a plurality of electrodes. A stimulus source provides stimuli to be delivered from the electrodes to neural tissue. Measurement circuitry obtains a measurement of a neural signal sensed at the electrodes. A control unit is configured to control application of a selected stimulus to neural tissue using the stimulus electrodes; and after the selected neural stimulus, apply a probe stimulus having a short pulse width. A remnant neural response evoked by the probe stimulus is measured; and the control unit estimates from the remnant neural response a neural recruitment caused by the selected neural stimulus.
    Type: Application
    Filed: March 21, 2018
    Publication date: September 13, 2018
    Applicant: Saluda Medical Pty. Ltd.
    Inventors: John Louis Parker, James Hamilton Laird, Dean Michael Karantonis
  • Patent number: 9974455
    Abstract: An implantable device for estimating neural recruitment arising from a stimulus, has a plurality of electrodes. A stimulus source provides stimuli to be delivered from the electrodes to neural tissue. Measurement circuitry obtains a measurement of a neural signal sensed at the electrodes. A control unit is configured to control application of a selected stimulus to neural tissue using the stimulus electrodes; and after the selected neural stimulus, apply a probe stimulus having a short pulse Width. A remnant neural response evoked by the probe stimulus is measured; and the control unit estimates from the remnant neural response a neural recruitment caused by the selected neural stimulus.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: May 22, 2018
    Assignee: Saluda Medical Pty Ltd.
    Inventors: John Louis Parker, James Hamilton Laird, Dean Michael Karantonis
  • Publication number: 20170071490
    Abstract: A method for measuring a neural response to a stimulus. Measurement circuitry is settled prior to a stimulus, by connecting a sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state. Charge is recovered on stimulus electrodes by short circuiting the stimulus electrodes to each other. An electrical stimulus is then applied from the stimulus electrodes to neural tissue, while keeping the sense electrode disconnected from the measurement circuitry. After the stimulus, a delay is imposed during which the stimulus electrodes are open circuited and the sense electrode is disconnected from the measurement circuitry and from the stimulus electrodes. After the delay, a neural response signal present at the sense electrode is measured by connecting the sense electrode to the measurement circuitry.
    Type: Application
    Filed: June 16, 2016
    Publication date: March 16, 2017
    Applicant: Saluda Medical Pty, Ltd.
    Inventors: John Louis Parker, Peter Scott Vallack Single, Dean Michael Karantonis
  • Patent number: 9386934
    Abstract: A method for measuring a neural response to a stimulus. Measurement circuitry is settled prior to a stimulus, by connecting a sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state. Charge is recovered on stimulus electrodes by short circuiting the stimulus electrodes to each other. An electrical stimulus is then applied from the stimulus electrodes to neural tissue, while keeping the sense electrode disconnected from the measurement circuitry. After the stimulus, a delay is imposed during which the stimulus electrodes are open circuited and the sense electrode is disconnected from the measurement circuitry and from the stimulus electrodes. After the delay, a neural response signal present at the sense electrode is measured by connecting the sense electrode to the measurement circuitry.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: July 12, 2016
    Assignee: Saluda Medical Pty Ltd.
    Inventors: John Louis Parker, Peter Scott Vallack Single, Dean Michael Karantonis
  • Patent number: 9381356
    Abstract: An implantable device applies and controls a neural stimulus. The device has a plurality of electrodes, and a stimulus source for providing a stimulus to be delivered from the electrodes to a neural pathway in order to evoke an action potential on the neural pathway, such as the spinal cord. A control unit controls application of a neural stimulus as defined by a set of parameter values and measures via measurement circuitry an evoked neural compound action potential response. The control unit determines from the measured evoked response a feedback variable, and compares it to a therapy map. The therapy map defines a therapeutic relationship of control variable to feedback variable. One or more of the stimulus parameter values are altered to effect the required change in the control variable. This process is performed iteratively to improve alignment of the feedback variable with the therapy map over time.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: July 5, 2016
    Assignee: Saluda Medical Pty Ltd.
    Inventors: John Louis Parker, James Hamilton Laird, Dean Michael Karantonis, Milan Obradovic, Robert Bruce Gorman
  • Publication number: 20150164354
    Abstract: A method for measuring a neural response to a stimulus. Measurement circuitry is settled prior to a stimulus, by connecting a sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state. Charge is recovered on stimulus electrodes by short circuiting the stimulus electrodes to each other. An electrical stimulus is then applied from the stimulus electrodes to neural tissue, while keeping the sense electrode disconnected from the measurement circuitry. After the stimulus, a delay is imposed during which the stimulus electrodes are open circuited and the sense electrode is disconnected from the measurement circuitry and from the stimulus electrodes. After the delay, a neural response signal present at the sense electrode is measured by connecting the sense electrode to the measurement circuitry.
    Type: Application
    Filed: May 11, 2012
    Publication date: June 18, 2015
    Inventors: John Louis Parker, Peter Scott Vallack Single, Dean Michael Karantonis
  • Publication number: 20140296737
    Abstract: A method for determining a desired location at which to apply a neural therapy. An array of electrodes is positioned proximal to neural tissue. A stimulus is applied from the array which evokes a neural compound action potential response in the neural tissue proximal to the array. A plurality of electrodes of the array simultaneously obtain respective measurements of the neural compound action potential response. From the measurements of the neural compound action potential response a desired location for a neural therapy is determined.
    Type: Application
    Filed: May 11, 2012
    Publication date: October 2, 2014
    Inventors: John Louis Parker, Dean Michael Karantonis
  • Publication number: 20140236257
    Abstract: An implantable device applies and controls a neural stimulus. The device has a plurality of electrodes, and a stimulus source for providing a stimulus to be delivered from the electrodes to a neural pathway in order to evoke an action potential on the neural pathway, such as the spinal cord. A control unit controls application of a neural stimulus as defined by a set of parameter values and measures via measurement circuitry an evoked neural compound action potential response. The control unit determines from the measured evoked response a feedback variable, and compares it to a therapy map. The therapy map defines a therapeutic relationship of control variable to feedback variable. One or more of the stimulus parameter values are altered to effect the required change in the control variable. This process is performed iteratively to improve alignment of the feedback variable with the therapy map over time.
    Type: Application
    Filed: May 11, 2012
    Publication date: August 21, 2014
    Applicant: Saluda Medical Pty. Ltd.
    Inventors: John Louis Parker, James Hamilton Laird, Dean Michael Karantonis, Milan Obradovic
  • Publication number: 20140236042
    Abstract: A method for estimating conduction velocity of a neural response. Measurements of the neural response are obtained from at least two electrodes which are at distinct locations along a neural pathway. A delay between the time of arrival of the neural response at each respective electrode is determined from the measurements. From the delay, and from knowledge of electrode spacing, a conduction velocity of the neural response is estimated.
    Type: Application
    Filed: May 11, 2012
    Publication date: August 21, 2014
    Applicant: Saluda Medical Pty. Ltd.
    Inventors: John Louis Parker, Dean Michael Karantonis
  • Publication number: 20140194771
    Abstract: An implantable device for estimating neural recruitment arising from a stimulus, has a plurality of electrodes. A stimulus source provides stimuli to be delivered from the electrodes to neural tissue. Measurement circuitry obtains a measurement of a neural signal sensed at the electrodes. A control unit is configured to control application of a selected stimulus to neural tissue using the stimulus electrodes; and after the selected neural stimulus, apply a probe stimulus having a short pulse width. A remnant neural response evoked by the probe stimulus is measured; and the control unit estimates from the remnant neural response a neural recruitment caused by the selected neural stimulus.
    Type: Application
    Filed: May 11, 2012
    Publication date: July 10, 2014
    Inventors: John Louis Parker, James Hamilton Laird, Dean Michael Karantonis